Dr. June Almenoff has been appointed chief operating officer and chief medical officer, Innovate Biopharmaceuticals, Inc. Dr. Almenoff brings more than 20 years of pharmaceutical executive experience from GlaxoSmithKline and from Furiex Pharmaceuticals. Dr. Almenoff previously served as president and chief medical officer at Furiex Pharmaceuticals, where during her tenure the company’s valuation increased ~10-fold, culminating in its acquisition by Actavis plc (now Allergan) for more than $1....